General News
Meropi Kyriacou Honored as TNH Educator of the Year
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
WASHINGTON — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.
The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old. Officials had said previously they would file an application with the FDA to authorize use in the coming weeks.
Once the company files its application, U.S. regulators and public health officials will review the evidence and consult with their advisory committees in public meetings to determine if the shots are safe and effective enough to recommend use.
That process may mean the shots may not be available until closer to Thanksgiving, according to a person familiar with the process but not authorized to discuss it publicly. But it is possible that, depending on how quickly the FDA acts, the shots could become available earlier in November, the person said.
The drugmaker and its partner, Germany's BioNTech, say they expect to request emergency use authorization of their vaccine in children ages 5 to 11 "in the coming weeks." The companies also plan to submit data to the European Medicines Agency and other regulators.
The two-shot Pfizer vaccine is currently available for those 12 and older. An estimated 100 million people in the U.S. have been fully vaccinated with it, according to the Centers for Disease Control and Prevention.
Pfizer tested a lower dose of the shots in children. The drugmaker said last week that researchers found the vaccine developed coronavirus-fighting antibody levels in children that were just as strong as those found in teenagers and young adults getting regular-strength doses.
Earlier this month, FDA chief Dr. Peter Marks told the AP that once Pfizer turns over its study results, his agency would evaluate the data "hopefully in a matter of weeks" to decide if the shots are safe and effective enough for younger kids.
Pfizer's updated timetable was first reported by The Wall Street Journal.
Another U.S. vaccine maker, Moderna, also is studying its shots in elementary school-aged children. Results are expected later in the year.
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
BERLIN (AP) — At least five people were killed Wednesday when a bus headed from Berlin to Switzerland came off a highway in eastern Germany and ended up on its side, authorities said.
FLORENCE, Italy (AP) — Michelangelo’s David has been a towering figure in Italian culture since its completion in 1504.
ATHENS — Police in Greece clashed late Wednesday with Communist-backed demonstrators who tried to prevent a concert by U.
BALTIMORE — The cargo ship that lost power and crashed into a bridge in Baltimore underwent “routine engine maintenance” in port beforehand, the U.
ΒΟSTON - The newly-elected Metropolitan Iakovos of Mexico, who was enthroned on Saturday, March 16th at the Cathedral of Aghia Sophia in Mexico City, gave his first interview as Metropolitan to The National Herald, which he described as a "historic newspaper," one he has known since childhood, as have his close relatives.